Formycon AG
XETRA:FYB

Watchlist Manager
Formycon AG Logo
Formycon AG
XETRA:FYB
Watchlist
Price: 26.1 EUR 1.95% Market Closed
Market Cap: 461.2m EUR

Wall Street
Price Targets

FYB Price Targets Summary
Formycon AG

Wall Street analysts forecast FYB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FYB is 50.08 EUR with a low forecast of 30.3 EUR and a high forecast of 136.5 EUR.

Lowest
Price Target
30.3 EUR
16% Upside
Average
Price Target
50.08 EUR
92% Upside
Highest
Price Target
136.5 EUR
423% Upside
Formycon AG Competitors:
Price Targets
ENTA
Enanta Pharmaceuticals Inc
35% Upside
BMRN
Biomarin Pharmaceutical Inc
55% Upside
EXAS
Exact Sciences Corp
1% Downside
SLS
Sellas Life Sciences Group Inc
60% Upside
KRYS
Krystal Biotech Inc
8% Downside
EVAX
Evaxion Biotech A/S
167% Upside
688235
Beigene Ltd
38% Upside
300685
Amoy Diagnostics Co Ltd
44% Upside

Revenue
Forecast

Revenue Estimate
Formycon AG

For the last 13 years the compound annual growth rate for Formycon AG's revenue is 65%. The projected CAGR for the next 4 years is 16%.

65%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Formycon AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Formycon AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is FYB's stock price target?
Price Target
50.08 EUR

According to Wall Street analysts, the average 1-year price target for FYB is 50.08 EUR with a low forecast of 30.3 EUR and a high forecast of 136.5 EUR.

What is Formycon AG's Revenue forecast?
Projected CAGR
16%

For the last 13 years the compound annual growth rate for Formycon AG's revenue is 65%. The projected CAGR for the next 4 years is 16%.

Back to Top